 |
Lumbar Artificial Disc Surgery
The Charité Artificial Disc is the first device of its kind to be approved by the U.S. Food and Drug Administration (FDA). The artificial disc, which is used to replace a damaged or worn spinal disc, is designed to be an alternative to spinal fusion surgery. Carolina Neurosurgery & Spine Associates performed the first implantation of a lumbar artificial disc in North or South Carolina.

Lumbar spinal fusion surgery, which is currently a common surgical treatment for low back pain or degenerative disc disease, is often effective in reducing pain, but limits a patients range of motion and may transfer extra stress to discs above and below the fusion site. More than 200,000 of these procedures are performed each year in the U.S.
The major benefits of the artificial disc over spinal fusion is that it not only allows a patient to maintain a larger range of motion, it decreases the stress placed on the discs above and below it.
Patients who receive an artificial disc can also expect a recovery period that is shorter than with spinal fusion surgery. With fusion surgery, patients generally require a three to four day hospital stay and usually cannot return to work for three to six months. Generally, a two to three day hospital stay is required after artificial disc surgery and patients may return to work in only one to three months.
The Artificial Disc Procedure
During the artificial disc procedure, the spine is approached through an incision in the abdomen. Internal organs and blood vessels are moved to provide access to the spine. The damaged disc is removed to create a space between two vertebrae for the implantation of the artificial disc.
By contrast, in spinal fusion surgery, a damaged spinal disc is removed and vertebrae are joined together using bone grafts and metal screws and/or cages so that motion can no longer occur in this area of the spine. Patients usually have to wear a brace for one to three months after surgery.
Who Is A Potential Candidate?
If a patient suffers from degenerative disc disease in the lumbar spine, and has not received adequate relief after at least six months of conservative treatment (pain medication, a back brace, or physical therapy), he or she may be a candidate for artificial disc replacement.
The Charité artificial disc is an alternative to spinal fusion for patients who have one diseased disc between L4 and L5 or between L5 and S1. Disc deterioration is determined by history and X-rays or other diagnostic imaging. Patients who have had some types of minor lower back surgery may still receive an artificial disc.
Who Is Not A Candidate?
Artificial disc surgery is not for everyone who experiences lower back pain. A patients occupation, activity, weight, condition of other levels of the spine, pregnancy, and allergies may influence whether artificial disc surgery is an option. An artificial disc should not be used if:
the patient has either an infection throughout the body or localized to the spine; or,
the patient has disc deterioration or instability at more than one spinal level; or,
if the patient has poor bone quality (osteoporosis or osteopenia).
A Regional Training Site
Two Carolina Neurosurgery & Spine Associates surgeons are providing training to other surgeons from around the country for the lumbar artificial disc at Carolinas Medical Center. This is the only training site in the Carolinas and one of 50 nationwide.
To learn more about the lumbar artificial disc, call 704-376-1605 or go to www.charitedisc.com.
Image provided courtesy of DuPuy Spine, Inc. copyright (c) 2004. Charité Artificial Disc is a trademark of Dupuy Spine, Inc. 3D imaging provided by Pixel Light Digital Media, Inc.
|
|
|
|
|
Our practice newsletter delivers insights into the latest treatment options available in the field of neurosurgery. Read our latest issue
|
|
|
|
We were the first in the Carolinas to inplant the FDA-approved Charité artificial disc. The disc is designed to be an alternative to spinal fusion. Learn more
|
|
|
|
As the primary provider of brain tumor services in the Charlotte region, our practice coordinates state-of-the-art treatment and patient support. Learn more
|
|
|
|
The Merci® Retriever is an innovative device that actually removes blood clots from the brain of patients experiencing ischemic stroke.
Learn more
|
|